Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study

CONCLUSIONS: Overall, clozapine was associated with a high response rate for the treatment of catatonia in patients with ASD. These naturalistic data support the use of clozapine for the treatment of catatonia in patients with ASD for whom lorazepam is either ineffective or partially effective.PMID:37526285 | DOI:10.1080/17512433.2023.2243820

Source: Expert Review of Clinical Pharmacology - August 1, 2023 Category: Drugs & Pharmacology Authors: Robyn P Thom Michael Wu Caitlin Ravichandran Christopher J McDougle Source Type: research